Clay Siegall – Man To Reckon With In Biotechnology Industry
Posted on : 01-26-2017 By : Samantha Pointer
In the field of biotechnology and cancer therapies and research, the contributions made by Clay Siegall are immense. He co-founded Seattle Genetics in 1998 and is currently the Chairman, President, and CEO of the company. Under his leadership, Seattle Genetics, which deals mostly in developing antibody-conjugates, received approval from FDA in 2011 for its first-ever ADC product named ADCETRIS.   With the help of a partnership with another pharmaceutical giant, Takeda Pharmaceutical Company, Clay Siegall has been able to promote ADCETRIS as a global brand with active distribution channels in…
Read More